Literature DB >> 10072295

Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network.

Y Nagai1, O Onodera, J Chun, W J Strittmatter, J R Burke.   

Abstract

Eight inherited neurodegenerative diseases are caused by genes with expanded CAG repeats coding for polyglutamine domains in the disease-producing proteins. The mechanism by which this expanded polyglutamine domain causes neurodegenerative disease is unknown, but nuclear and cytoplasmic polyglutamine protein aggregation is a common feature. In transfected COS7 cells, expanded polyglutamine proteins aggregate and disrupt the vimentin intermediate filament network. Since neurons have an intermediate filament network composed of neurofilament (NF) and NF abnormalities occur in neurodegenerative diseases, we examined whether pathologic-length polyglutamine domain proteins also interact with NF. We expressed varying lengths polyglutamine-green fluorescent protein fusion proteins in a neuroblast cell line, TR1. Pathologic-length polyglutamine-GFP fusion proteins formed large cytoplasmic aggregates surrounded by neurofilament. Immunoisolation of pathologic-length polyglutamine proteins coisolated 68-kDa NF protein demonstrating molecular interaction. These observations suggest that polyglutamine interaction with NF is important in the pathogenesis of the polyglutamine repeat diseases. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072295     DOI: 10.1006/exnr.1998.6991

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.

Authors:  Michal Wegrzynowicz; Hunter K Holt; David B Friedman; Aaron B Bowman
Journal:  J Proteome Res       Date:  2012-01-20       Impact factor: 4.466

Review 2.  Of mice and men: solving the molecular mysteries of Huntington's disease.

Authors:  P F Shelbourne
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

3.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.

Authors:  James F Morley; Heather R Brignull; Jill J Weyers; Richard I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

4.  Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.

Authors:  Nobuhiro Fujikake; Yoshitaka Nagai; H Akiko Popiel; Yuma Okamoto; Masamitsu Yamaguchi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2008-07-16       Impact factor: 5.157

5.  The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases.

Authors:  H Akiko Popiel; James R Burke; Warren J Strittmatter; Shinya Oishi; Nobutaka Fujii; Toshihide Takeuchi; Tatsushi Toda; Keiji Wada; Yoshitaka Nagai
Journal:  J Amino Acids       Date:  2011-06-30

6.  Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.

Authors:  S T Suhr; M C Senut; J P Whitelegge; K F Faull; D B Cuizon; F H Gage
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

7.  Late onset of motor neurons in mice overexpressing wild-type peripherin.

Authors:  J M Beaulieu; M D Nguyen; J P Julien
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

Review 8.  Huntington's disease: the past, present, and future search for disease modifiers.

Authors:  Erin B D Clabough
Journal:  Yale J Biol Med       Date:  2013-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.